Columbus, Ohio
Phase 1 colorectal cancer trials in Columbus, OH
14 Phase 1 colorectal cancer studies are recruiting participants at sites in Columbus as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Columbus at a glance
- 14 studies are recruiting at a site in Columbus.
- By phase: Phase 1 (6), Phase 1/2 (8).
- By sponsor: industry (12), government (2).
- Most recent update to one of these records: November 9, 2026.
Studies recruiting in Columbus
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT06102902 · updated
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- The Ohio State University (OSU) Wexner Medical Center
- Registry record
- NCT06400472 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- The Jame Outpatient Care West Campus
- Registry record
- NCT07397338 · updated
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study site
- Ohio State University
- Registry record
- NCT03526835 · updated
Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study site
- Ohio State University
- Registry record
- NCT06710756 · updated
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT05630794 · updated
SMP-3124LP in Adults With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Sumitomo Pharma America, Inc.
- Study site
- Ohio State University
- Registry record
- NCT06526819 · updated
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kura Oncology, Inc.
- Study site
- Ohio State University
- Registry record
- NCT06026410 · updated
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- ALX Oncology Inc.
- Study site
- ALX Center 10
- Registry record
- NCT07085091 · updated
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Marengo Therapeutics, Inc.
- Study site
- The Ohio State University Comprehensive Cancer Center
- Registry record
- NCT05592626 · updated
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Xencor, Inc.
- Study site
- Xencor Investigative Site
- Registry record
- NCT05433142 · updated
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- Turning Point Therapeutics, Inc.
- Study site
- The Ohio State University Wexner Medical Center
- Registry record
- NCT03093116 · updated
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- 858 Therapeutics, Inc.
- Study site
- Stefanie Spielman Comprehensive Breast Center
- Registry record
- NCT06395519 · updated
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- A2 Biotherapeutics Inc.
- Study site
- The Ohio State University
- Registry record
- NCT06682793 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Columbus, OH on ClinicalTrials.gov.
Ask about studies near Columbus
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Ohio
All Ohio locations
43 studies recruiting across 6 cities.
Cleveland
20 studies recruiting.
Cincinnati
12 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections